** Radiopharm Theranostics RAD.AX leaps as much as 50% to A$0.036; set for biggest ever intraday pct gain
** Biopharma secures private placement agreement with Massachusetts-based Lantheus Holdings LNTH.O to raise $5 mln
** Issue price of A$0.060 represents 150% premium to last close
** Co earlier signed co-development deal with the NASDAQ-listed firm to develop biopharmaceuticals in Australia
** Stock hits its highest level since Dec. 10, 2024
** More than 12.9 mln shares traded, 1.2x the 30-day avg
** RAD fell 67.6% in 2024 - third consecutive bear run since 2022
(Reporting by Kumar Tanishk in Bengaluru)
((Tanishk.Kumar@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.